Cargando…

Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis

An intensive short-term chemotherapy regimen has substantially prolonged the overall survival of Burkitt’s lymphoma (BL) patients, which has been further improved by addition of rituximab. However, the inevitable development of resistance to rituximab and the toxicity of chemotherapy remain obstacle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Xiaowen, Chen, Jianfeng, Li, Ling, Ding, Peipei, Wang, Qi, Zhang, Wei, Li, Luying, Lv, Xinyue, Zhou, Danlei, Jiang, Zhengzeng, Zeng, Haiying, Xu, Yifan, Hou, Yingyong, Hu, Weiguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315025/ https://www.ncbi.nlm.nih.gov/pubmed/30584254 http://dx.doi.org/10.1038/s41419-018-1259-5

Ejemplares similares

CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity
por: Li, Luying, et al.
Publicado: (2022)

Herbal NF-κB Inhibitors Sensitize Rituximab-Resistant B Lymphoma Cells to Complement-Mediated Cytolysis
por: Ge, Xiaowen, et al.
Publicado: (2021)

A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course
por: Ge, Xiaowen, et al.
Publicado: (2018)

Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis
por: Hong, Junshik, et al.
Publicado: (2015)

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis
por: Lu, Xiaoxuan, et al.
Publicado: (2022)

Burkitt Lymphoma in the Mouse
por: Kovalchuk, Alexander L., et al.
Publicado: (2000)

Burkitt Lymphoma of the Duodenum
por: Matsueda, Katsunori, et al.
Publicado: (2017)

Burkitt's lymphoma of the mandible
por: Kuo, Ying-Shiung, et al.
Publicado: (2017)

Burkitt lymphoma involving jejunum in children
por: Li, Zhi, et al.
Publicado: (2014)

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab
por: Dunleavy, K, et al.
Publicado: (2009)

Role and mechanism of PTEN in Burkitt's lymphoma
por: Li, Chuntuan, et al.
Publicado: (2020)

Excretion of Immunoglobulins in Burkitt's Lymphoma
por: McFarlane, H., et al.
Publicado: (1970)

Pleural effusion in Burkitt's lymphoma.
por: Aderele, W. I., et al.
Publicado: (1975)

Cytology and Histochemistry of the Burkitt Lymphoma
por: Wright, D. H.
Publicado: (1963)

The next step for Burkitt lymphoma
por: Cho, Bin
Publicado: (2011)

Denis Burkitt and the African lymphoma
por: Magrath, I
Publicado: (2009)

Burkitts’s lymphoma – an atypical presentation
por: Ziade, Farah, et al.
Publicado: (2012)

Seasonality of Burkitt's lymphoma in Uganda
por: Muwazi, L, et al.
Publicado: (2014)

Primary Gastric Burkitt’s Lymphoma
por: Mitra, Swarupa, et al.
Publicado: (2014)

Burkitt Lymphoma: beyond discoveries
por: Mbulaiteye, Sam M
Publicado: (2013)

Primary Gastric Burkitt’s lymphoma:
por: khan, Adnan, et al.
Publicado: (2017)

The burden of Burkitt lymphoma in Africa
por: Hämmerl, Lucia, et al.
Publicado: (2019)

Educational Case: Burkitt Lymphoma
por: Alexander, Caitlin J., et al.
Publicado: (2019)

PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma
por: Chen, Jianfeng, et al.
Publicado: (2020)

PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits
por: Wang, Qi, et al.
Publicado: (2020)

FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis
por: Zhang, Wei, et al.
Publicado: (2021)

Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer
por: Wang, Xiaochao, et al.
Publicado: (2023)

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2019)

Increased α-HB links colorectal cancer and diabetes by potentiating NF-κB signaling
por: Lv, Xinyue, et al.
Publicado: (2023)

Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children
por: Zhu, Jia, et al.
Publicado: (2021)

Clinical potential of midostaurin in advanced systemic mastocytosis
por: Chandesris, Marie Olivia, et al.
Publicado: (2017)

Status and prognostic nomogram of patients with Burkitt lymphoma
por: Lu, Jielun, et al.
Publicado: (2020)

Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab
por: Huang, Shuang, et al.
Publicado: (2021)

Burkitt lymphoma in Papua, New Guinea.
por: Booth, K., et al.
Publicado: (1967)

Survival of Burkitt's Lymphoma Patients in Ghana
por: Wosornu, J. L., et al.
Publicado: (1971)

Burkitt's Lymphoma in Ilesha, Western Nigeria
por: Mulligan, T. O.
Publicado: (1971)

Abdominal Burkitt-type lymphomas in Algeria.
por: Ladjadj, Y., et al.
Publicado: (1984)

Burkitt lymphoma masquerading as cardiac tamponade
por: Kaul, Pankaj, et al.
Publicado: (2007)

Burkitt Lymphoma: Pathogenesis and Immune Evasion
por: God, Jason M., et al.
Publicado: (2010)

Orbital Burkitt's Lymphoma: An Aggressive Presentation
por: Giuliari, Gian Paolo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m8ajrrl4sj7cav8fkvfpoanb9t